Thursday, July 23, 2026

6 wks
Second death reported in New York City Legionnaires' outbreak (4)
6 wks
FDA scrutinizes peptide injections popularized by RFK Jr. and influencers (13) hot
FDA review and RFK Jr. clash over influencer‑favored peptides
Advisory panel votes to expand compounding despite safety warnings
Market hype and regulation: guidances, reporting and uncertainty


In Detail Full day, Thursday, July 23, 2026, Timezone: America/Chicago

Walid Kamoun: Breakthroughs Begin With the Right Questions and the Courage to Pursue Them

oncodaily - Walid Kamoun, Vice President, Global Head of R/D Oncology at Servier, shared The Nobel Prize’s post on LinkedIn, adding: “In this inspiring video, Tasuku Honjo reminds us that breakthrough innovation […]

AI Summary: Health officials confirmed a second fatality tied to a Legionnaires' disease outbreak in New York City, prompting intensified environmental testing and public‑health interventions. Authorities are tracing sources, inspecting water systems and issuing guidance to vulnerable populations while hospitals manage a surge of severe respiratory infections.

#healthcare #publichealth #governmentpolicy #hospitaloperations #infectiousdisease #diagnostics
Healthcare RSSPublic Health RSSGovernment Policy RSSHospital Operations RSSInfectious Disease RSSDiagnostics RSS

Legionnaires’ Disease Has Made a Home in New York City. Here’s How.

5 wks / nytimes / Joseph Goldstein

Walid Kamoun: Breakthroughs Begin With the Right Questions and the Courage to Pursue Them

6 wks / oncodaily

Second death reported in Legionnaires' disease outbreak in New York City

6 wks / medicalxpress

Second death reported in Legionnaires’ disease outbreak in New York City

6 wks / abcnews

Back to Top / Thu, July 23, 2026, 7:22 pm / permalink 27567 / 4 stories in 6 wks /



A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda

Christina Jewett and Dana G. Smith / nytimes - Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.

AI Summary: Federal regulators have zeroed in on a set of peptide injections gaining traction among wellness influencers and endorsed by RFK Jr., prompting internal debates about safety, evidence and regulation. FDA scientists are reviewing the products' claims and potential risks, setting up a clash between celebrity-driven demand and the agency’s evidence-based caution.


Advisory panel votes to expand compounding despite safety warnings

ECRI, ISMP warn against FDA panel’s peptide compounding vote

5 wks / beckershospitalreview / Ella Jeffries

US panel endorses more unproven if buzzy peptides

6 wks / medicalxpress

F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing Boom

6 wks / nytimes / Christina Jewett and Dana G. Smith

FDA advisers dismiss safety warnings, back four peptide treatments

6 wks / medicalxpress


FDA review and RFK Jr. clash over influencer‑favored peptides

What to Know About Peptides the FDA Is Considering for Use

6 wks / nytimes / Dana G. Smith

A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s Agenda

6 wks / nytimes / Christina Jewett and Dana G. Smith

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

6 wks / medicalxpress

FDA reviews peptide injections favored by RFK Jr. and wellness influencers

6 wks / abcnews


Market hype and regulation: guidances, reporting and uncertainty

National pharmacy association to develop compounded drug reporting system

5 wks / beckershospitalreview / Ella Jeffries

FDA releases 17 peptide drug guidances

5 wks / beckershospitalreview / Ella Jeffries

Longevity medicine has gone peptide-crazy

5 wks / medicalxpress

Peptides are the latest wellness trend – but do they work?

5 wks / newscientist / Grace Wade

What's the deal with peptides? The hyped market under US review

6 wks / medicalxpress







StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Telemedicine, Rural Health, Neuroscience, Wildlife and look for the RSS link.

More StackHealth



Back to Top
↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.